Ginsenoside Compound K Promotes Intestinal Peristalsis and the Pharmacokinetic of Metabolite 20(S)-Protopanaxadiol in Relation to Diarrhea

Table 1

Demographics of the study participants.

Sample	^a	Nondiarrhea				Diarrhea
		Age (years)	Height (m)	Weight (kg)	BMI (kg·m^-2)	Age (years)	Height (m)	Weight (kg)	BMI (kg·m^-2)
Sample 1	30
Sample 2	24
Sample 3	28

Sample 1 was pooled from three dose (100, 200, and 400 mg G-CK) groups of the single-dose trial; sample 2 was pooled from the food-effect trial (200 mg of G-CK under the fed condition); sample 3 was pooled from three dose (100, 200, and 400 mg G-CK) groups of the multiple-dose trial. All values are presented as the . SD: standard deviation; G-CK: ginsenoside compound K; BMI: body mass index. ^aNumber of participants. Diarrhea vs. nondiarrhea: the independent sample -test.